We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BIOX market cap is 418.57M. The company's latest EPS is USD 0.0996 and P/E is 66.87.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 326.2M | 116.59M | 140.2M | 380.88M | 93.3M |
| Operating Income | 27.51M | 5.3M | 16.7M | 32.92M | 2.9M |
| Net Income | -7.68M | -2.68M | 1.2M | -3.54M | -5.3M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 173.09M | 209.53M | 334.8M | 416.79M | 464.78M |
| Operating Income | 39.15M | 38.38M | 39.87M | 54.18M | 44.82M |
| Net Income | 4.24M | -3.82M | -3.91M | 20.18M | 6.26M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 824.1M | 819.7M | 817.2M | 850.63M | 827.5M |
| Total Liabilities | 494M | 487.07M | 481.9M | 501.06M | 481.6M |
| Total Equity | 330.1M | 332.62M | 335.3M | 349.56M | 345.9M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 297.56M | 394.59M | 518.22M | 818.06M | 850.63M |
| Total Liabilities | 236.81M | 304.3M | 359.92M | 487.56M | 501.06M |
| Total Equity | 60.75M | 90.29M | 158.3M | 330.5M | 349.56M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | 14.73M | N/A | 41.72M | N/A |
| Investing | N/A | -8.69M | N/A | -28.73M | N/A |
| Financing | N/A | -26.98M | N/A | -10.06M | N/A |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 11.42M | -6.21M | -17.52M | 2.59M | 41.72M |
| Investing | -22.21M | -8.31M | 2.9M | -25.73M | -28.73M |
| Financing | 33.53M | 7.36M | 14.82M | 32.95M | -10.06M |
| Market Cap | 418.57M |
| Price to Earnings Ratio | 66.87 |
| Price to Sales Ratio | 0.9 |
| Price to Cash Ratio | 9.41 |
| Price to Book Ratio | 1.2 |
| Dividend Yield | - |
| Shares Outstanding | 62.85M |
| Average Volume (1 week) | 191.58k |
| Average Volume (1 Month) | 212.12k |
| 52 Week Change | -50.78% |
| 52 Week High | 14.05 |
| 52 Week Low | 5.71 |
| Spread (Intraday) | 0.52 (7.38%) |
| Company Name | Bioceres Crop Solutions Corp |
| Address |
ocampo 210 bis rosario, santa fe |
| Website | https://biocerescrops.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
